PRA Health Sciences, Inc. logo
PRA Health Sciences, Inc. PRAH

PRA Health Sciences, Inc. Revenue | PRAH

Company revenue is the total amount of money received from the sale of goods or services over a certain period of time. It is one of the key indicators of a company's financial condition and success.

Traditionally defined as follows:
Revenue = Price * Quantity of products

Revenue is one of the components of a company’s income. In international practice, revenue is understood as the inflow or other increase in a company's assets or the settlement of its obligations that occurs as a result of the company’s core or main activity.[1]

This is an important indicator for assessing the financial condition and efficiency of a company. It makes it possible to determine how successfully a company sells its products or services on the market. In addition, revenue can be used to calculate other financial indicators such as profit, profitability, and market share.

Various factors can influence this indicator, including demand for goods or services, market competition, economic conditions, and the company's marketing efforts. Therefore, its analysis and monitoring are important tasks for the successful development of a business.

Annual Revenue PRA Health Sciences, Inc.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
3.18 B 3.07 B 2.87 B 2.26 B 1.81 B 1.61 B 1.46 B - 700 M -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
3.18 B 700 M 2.12 B

References

  1. Adhikari, B. (2010). Impact of Revenue Planning In Nepal Investment Bank Limited (Doctoral dissertation, Faculty of Management).

Revenue of other stocks in the Diagnostics research industry

Issuer Revenue Price % 24h Market Cap Country
Enzo Biochem Enzo Biochem
ENZ
31.9 M - -8.98 % $ 14.8 K usaUSA
Renalytix AI plc Renalytix AI plc
RNLX
2.29 M - 5.66 % $ 22.7 M britainBritain
DexCom DexCom
DXCM
4.66 B $ 82.53 0.6 % $ 32.2 B usaUSA
Meridian Bioscience Meridian Bioscience
VIVO
333 M - - $ 1.49 B usaUSA
Heska Corporation Heska Corporation
HSKA
257 M - - $ 1.31 B usaUSA
Accelerate Diagnostics Accelerate Diagnostics
AXDX
11.7 M - -61.36 % $ 2.46 M usaUSA
T2 Biosystems T2 Biosystems
TTOO
7.19 M - -39.35 % $ 313 K usaUSA
Syneos Health Syneos Health
SYNH
5.39 B - - $ 4.46 B usaUSA
Biocept Biocept
BIOC
25.9 M - -13.05 % $ 7.29 M usaUSA
Invitae Corporation Invitae Corporation
NVTA
122 M - - $ 21.2 M usaUSA
Quotient Limited Quotient Limited
QTNT
38.5 M - -11.32 % $ 1.1 M schweizSchweiz
DermTech DermTech
DMTK
15.3 M - -11.32 % $ 2.94 M usaUSA
Surmodics Surmodics
SRDX
126 M - - $ 608 M usaUSA
Brainsway Ltd. Brainsway Ltd.
BWAY
41 M $ 9.02 -1.04 % $ 306 M israelIsrael
Akumin Akumin
AKU
750 M - -17.87 % $ 25.9 M canadaCanada
Psychemedics Corporation Psychemedics Corporation
PMD
19.7 M - -1.84 % $ 15.3 M usaUSA
Danaher Corporation Danaher Corporation
DHR
24.6 B $ 228.43 1.18 % $ 163 B usaUSA
Chembio Diagnostics Chembio Diagnostics
CEMI
49.5 M - 0.22 % $ 16.8 M usaUSA
Motus GI Holdings Motus GI Holdings
MOTS
319 K - -34.28 % $ 263 K israelIsrael
HTG Molecular Diagnostics HTG Molecular Diagnostics
HTGM
6.37 M - -20.0 % $ 1.06 M usaUSA
Anixa Biosciences Anixa Biosciences
ANIX
210 K $ 2.72 1.87 % $ 88.3 K usaUSA
Biodesix Biodesix
BDSX
88.5 M $ 8.42 -5.18 % $ 63.6 M usaUSA
Agilent Technologies Agilent Technologies
A
6.95 B $ 176.32 2.38 % $ 50.1 B usaUSA
BioNano Genomics BioNano Genomics
BNGO
28.5 M $ 0.98 3.13 % $ 5.34 M usaUSA
Burning Rock Biotech Limited Burning Rock Biotech Limited
BNR
540 M $ 12.85 2.8 % $ 135 M chinaChina
Bioventus Bioventus
BVS
568 M $ 10.64 0.38 % $ 709 M usaUSA
Quest Diagnostics Incorporated Quest Diagnostics Incorporated
DGX
11 B $ 259.18 1.1 % $ 28.8 B usaUSA
Charles River Laboratories International Charles River Laboratories International
CRL
4.02 B $ 333.37 0.36 % $ 16.5 B usaUSA
Guardant Health Guardant Health
GH
982 M $ 145.11 1.28 % $ 18.2 B usaUSA
Castle Biosciences Castle Biosciences
CSTL
344 M $ 33.41 1.3 % $ 968 M usaUSA
Illumina Illumina
ILMN
4.34 B $ 209.18 3.24 % $ 32.4 B usaUSA
IQVIA Holdings IQVIA Holdings
IQV
16.3 B $ 257.93 0.13 % $ 44.3 B usaUSA
Laboratory Corporation of America Holdings Laboratory Corporation of America Holdings
LH
14 B $ 370.49 0.61 % $ 30.8 B usaUSA
IDEXX Laboratories IDEXX Laboratories
IDXX
4.3 B $ 700.79 1.53 % $ 56.4 B usaUSA
Medpace Holdings Medpace Holdings
MEDP
2.53 B $ 647.03 -0.93 % $ 18.7 B usaUSA
Mettler-Toledo International Mettler-Toledo International
MTD
4.03 B $ 1 734.36 1.25 % $ 35.7 B schweizSchweiz
Natera Natera
NTRA
2.31 B $ 286.77 -0.25 % $ 39.2 B usaUSA
Lantheus Holdings Lantheus Holdings
LNTH
1.54 B $ 102.03 0.23 % $ 6.89 B usaUSA
Fulgent Genetics Fulgent Genetics
FLGT
323 M $ 25.14 3.84 % $ 774 M usaUSA
CareDx, Inc CareDx, Inc
CDNA
380 M $ 74.4 -0.21 % $ 3.96 B usaUSA
Oxford Immunotec Global PLC Oxford Immunotec Global PLC
OXFD
73.7 M - - $ 562 M britainBritain
Biomerica Biomerica
BMRA
4.45 M $ 1.15 -6.88 % $ 3.35 M usaUSA
Interpace Biosciences Interpace Biosciences
IDXG
38.7 M $ 5.44 -9.42 % $ 24.1 M usaUSA
Fluidigm Corporation Fluidigm Corporation
FLDM
138 M - 1.08 % $ 308 M usaUSA
ICON Public Limited Company ICON Public Limited Company
ICLR
8.25 B $ 194.96 -0.03 % $ 15.3 B irlandaIrlanda
Senseonics Holdings Senseonics Holdings
SENS
35.3 M $ 9.76 -3.99 % $ 407 M usaUSA
Sotera Health Company Sotera Health Company
SHC
1.16 B $ 16.27 1.34 % $ 4.62 B usaUSA
Co-Diagnostics Co-Diagnostics
CODX
622 K $ 0.2 1.99 % $ 266 K usaUSA
Precipio Precipio
PRPO
24 M $ 18.8 -1.93 % $ 30.2 M usaUSA